Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.250 $0.685 Friday, 10th May 2024 ADXS stock ended at $0.437. This is 21.96% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 108.00% from a day low at $0.250 to a day high of $0.520.
90 days $0.250 $1.05
52 weeks $0.250 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Aug 11, 2016 $212.25 $212.25 $212.25 $212.25 175 753
Aug 10, 2016 $222.00 $222.00 $222.00 $222.00 120 213
Aug 09, 2016 $239.70 $239.70 $239.70 $239.70 146 513
Aug 08, 2016 $227.25 $227.25 $227.25 $227.25 214 840
Aug 05, 2016 $213.90 $213.90 $213.90 $213.90 149 260
Aug 04, 2016 $192.90 $192.90 $192.90 $192.90 281 627
Aug 03, 2016 $205.35 $205.35 $205.35 $205.35 385 100
Aug 02, 2016 $166.20 $166.20 $166.20 $166.20 427 920
Aug 01, 2016 $127.05 $127.05 $127.05 $127.05 26 527
Jul 29, 2016 $125.10 $125.10 $125.10 $125.10 20 173
Jul 28, 2016 $122.70 $122.70 $122.70 $122.70 21 087
Jul 27, 2016 $125.10 $125.10 $125.10 $125.10 30 633
Jul 26, 2016 $120.45 $120.45 $120.45 $120.45 14 213
Jul 25, 2016 $118.50 $118.50 $118.50 $118.50 23 440
Jul 22, 2016 $117.60 $117.60 $117.60 $117.60 20 300
Jul 21, 2016 $117.75 $117.75 $117.75 $117.75 62 113
Jul 20, 2016 $113.55 $113.55 $113.55 $113.55 42 493
Jul 19, 2016 $113.40 $113.40 $113.40 $113.40 41 787
Jul 18, 2016 $117.00 $117.00 $117.00 $117.00 35 000
Jul 15, 2016 $122.10 $122.10 $122.10 $122.10 30 060
Jul 14, 2016 $121.80 $121.80 $121.80 $121.80 25 867
Jul 13, 2016 $124.95 $124.95 $124.95 $124.95 33 947
Jul 12, 2016 $130.20 $130.20 $130.20 $130.20 23 347
Jul 11, 2016 $130.05 $130.05 $130.05 $130.05 27 920
Jul 08, 2016 $129.15 $129.15 $129.15 $129.15 37 700
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT